Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 1
2023 3
2024 5
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV Clinic.
Christopoulos KA, Grochowski J, Mayorga-Munoz F, Hickey MD, Imbert E, Szumowski JD, Dilworth S, Oskarsson J, Shiels M, Havlir D, Gandhi M. Christopoulos KA, et al. Clin Infect Dis. 2023 Feb 8;76(3):e645-e651. doi: 10.1093/cid/ciac631. Clin Infect Dis. 2023. PMID: 35913500 Free PMC article.
Are Patients and Their Providers Talking About Long-Acting Injectable Antiretroviral Therapy? Penetration into Clinical Encounters at Three U.S. Care Sites.
Christopoulos KA, Colasanti J, Johnson MO, Diaz Tsuzuki M, Erguera XA, Flores R, Kerman J, Dance K, Sauceda JA, Neilands TB, Dilworth SE, Koester KA, Gutierrez J, Schneider JA, Montgomery E, McNulty MC. Christopoulos KA, et al. Open Forum Infect Dis. 2022 Jun 11;9(7):ofac293. doi: 10.1093/ofid/ofac293. eCollection 2022 Jul. Open Forum Infect Dis. 2022. PMID: 35873299 Free PMC article.
Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir-Rilpivirine in People With HIV Who Are Virally Unsuppressed.
Hickey MD, Grochowski J, Mayorga-Munoz F, Oskarsson J, Imbert E, Spinelli M, Szumowski JD, Appa A, Koester K, Dauria EF, McNulty M, Colasanti J, Havlir DV, Gandhi M, Christopoulos KA. Hickey MD, et al. J Acquir Immune Defic Syndr. 2024 Jul 1;96(3):280-289. doi: 10.1097/QAI.0000000000003421. J Acquir Immune Defic Syndr. 2024. PMID: 38534179
Patient Attitudes Toward Self- or Partner-, Friend-, or Family-Administered Long-acting Injectable Antiretroviral Therapy: A Mixed-Methods Study Across 3 Urban Human Immunodeficiency Virus Clinics.
Collins LF, Koester KA, McNulty MC, Montgomery ET, Johnson MO, Neilands TB, Dilworth SE, Sauceda JA, Dance K, Erguera X, Diaz Tsuzuki M, Gutierrez JI Jr, Christopoulos KA, Colasanti JA. Collins LF, et al. Open Forum Infect Dis. 2024 May 13;11(6):ofae265. doi: 10.1093/ofid/ofae265. eCollection 2024 Jun. Open Forum Infect Dis. 2024. PMID: 38854389 Free PMC article.
Acceptability of Long-Acting Injectable Antiretroviral Therapy Among People with HIV Receiving Care at Three Ryan White Funded Clinics in the United States.
Erguera XA, Koester KA, Diaz Tsuzuki M, Dance KV, Flores R, Kerman J, McNulty MC, Colasanti JA, Collins LF, Montgomery ET, Johnson MO, Sauceda JA, Christopoulos KA. Erguera XA, et al. AIDS Behav. 2024 Jul;28(7):2226-2238. doi: 10.1007/s10461-024-04315-0. Epub 2024 Apr 10. AIDS Behav. 2024. PMID: 38598026 Free PMC article.
Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long-acting cabotegravir/rilpivirine among early adopters in three U.S. clinics.
Christopoulos KA, Smith MB, Pareek P, Dawdani A, Erguera XA, Dance KV, Walker RS, Grochowski J, Mayorga-Munoz F, Hickey MD, Johnson MO, Sauceda J, Gutierrez JI Jr, Montgomery ET, Colasanti JA, Collins LF, McNulty MC, Koester KA. Christopoulos KA, et al. J Int AIDS Soc. 2024 Nov;27(11):e26394. doi: 10.1002/jia2.26394. J Int AIDS Soc. 2024. PMID: 39568168 Free PMC article.